Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis [clinicaltrials:NCT00282555]

Bio2RDF uri

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis [clinicaltrials:NCT00282555]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00282555

Bio2RDF identifier

NCT00282555

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00282555

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00282555

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:ab00ee345cd7514e973bd1148be3468b

brief summary [clinicaltrials_vocabulary:brief-summary]

STU-Na belongs to the p ...... administered to the patient.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Esophageal endoscopy: assessment of achievement of grade "not present" in the Los Angeles scale of esophagitis after two weeks of treatment [clinicaltrials_resource:d349a4b456ca57ba0abb6004c52372aa]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Esophageal endoscopy: assessment of achievement of grade "not present" in the Los Angeles scale of esophagitis after two weeks of treatment [clinicaltrials_resource:1ac308e47be3174daab5fb6de00bbddb]

Esophageal endoscopy: assessment of achievement of grade "not present" in the Los Angeles scale of esophagitis after two weeks of treatment [clinicaltrials_resource:46613e56a039e5c9c134389967043792]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00282555 [clinicaltrials_resource:dd63d822b8d17a8a426897b649cce30e]

enrollment [clinicaltrials_vocabulary:enrollment]

450

http://www.w3.org/2001/XMLSchema#integer

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2006-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

S-Tenatoprazole-Na (STU-Na) [clinicaltrials_resource:8a855a4cbb3983f63e6b7d4c6fbf59bb]

keyword [clinicaltrials_vocabulary:keyword]

Esophageal endoscopy

http://www.w3.org/2001/XMLSchema#string

Esophagitis, Reflux

http://www.w3.org/2001/XMLSchema#string

Heartburn

http://www.w3.org/2001/XMLSchema#string

S-Tenatoprazole-Na

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2008-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

STEBA France [clinicaltrials_resource:5d56395eb4d262ceb7a4480986ebfa2d]

location [clinicaltrials_vocabulary:location]

St. Joseph's Healthcare [clinicaltrials_resource:7613600f937211c0d1994fa94e04cfab]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00282555

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

Assessment of the Healing Rate ...... e-Blind, Parallel Group Study.

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

HEC/STU(-Na)05816N/TU 2.05

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Alan Thomson, MD, Prof. [clinicaltrials_resource:467de9a6b16ec3c44308ec2e467e7862]

overall status [clinicaltrials_vocabulary:overall-status]

Suspended [clinicaltrials_resource:8bf906833cc7aea8084f552217ed9c1d]

oversight [clinicaltrials_vocabulary:oversight]

Canada: Health Canada [clinicaltrials_resource:e6098b05e05c8354a1fc6059fa3ffd77]

phase [clinicaltrials_vocabulary:phase]

Phase 2 [clinicaltrials_resource:56e0338b27a2d68f77402c88327b3f8d]

reference [clinicaltrials_vocabulary:reference]

10364004 [pubmed:10364004]

10385219 [pubmed:10385219]

10389120 [pubmed:10389120]

10403727 [pubmed:10403727]

10450061 [pubmed:10450061]

10594397 [pubmed:10594397]

10930890 [pubmed:10930890]

10963283 [pubmed:10963283]

1397746 [pubmed:1397746]

15023167 [pubmed:15023167]

source [clinicaltrials_vocabulary:source]

STEBA France [clinicaltrials_resource:5d56395eb4d262ceb7a4480986ebfa2d]

start date [clinicaltrials_vocabulary:start-date]

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00282555 study design [clinicaltrials_resource:97ea7e53727e5ff57814a2b3cdc29969]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00282555

verification date [clinicaltrials_vocabulary:verification-date]

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00282555

http://www.w3.org/2001/XMLSchema#string

title

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Efficiency Study of S-Tenatopr ...... s [clinicaltrials:NCT00282555]

@en